Skip to main content

pKF-P14MMP2AG-T2APuroR-5h
(Plasmid #128256)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 128256 Standard format: Plasmid sent in bacteria as agar stab 1 $94
DNA 128256-D50 50 μg of DNA in Tris buffer $495
DNA 128256-D100 100 μg of DNA in Tris buffer $585

Backbone

  • Vector backbone
    pKF-P14MM2AG5h
  • Backbone manufacturer
    Custom
  • Backbone size w/o insert (bp) 6246
  • Total vector size (bp) 6854
  • Modifications to backbone
    Replaced rtTA::P2A::EGFP with insert.
  • Vector type
    Mammalian Expression, Synthetic Biology ; Flp-In expression vector
  • Selectable markers
    Hygromycin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    rtTA-Advanced::P2A::EGFP::T2A::PuroR
  • Alt name
    reverse tetracycline Trans Activator (rtTA)
  • Alt name
    EGFP
  • Alt name
    PuroR
  • Species
    Synthetic
  • Insert Size (bp)
    2217
  • Promoter tight TRE promoter

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site SacI (not destroyed)
  • 3′ cloning site NotI (not destroyed)
  • 5′ sequencing primer ATATACGCGTCGAGGCCCTTTC
  • 3′ sequencing primer GCGGCCGCACCGGTTCAGGCACCGGGCTTGCG
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry

Trademarks:

  • Zeocin® is an InvivoGen trademark.

Depositor Comments

This plasmid encodes a synthetic gene circuit with positive feedback from rtTA activating the tight TRE promoter to control PuroR gene expression in an Flp-In expression vector. The custom backbone is missing the PuroR gene. We used overlap extension to replace the rtTA::P2A::EGFP fragment in the backbone with the new insert. The synthetic gene circuit is also called mPF-PuroR.

Purpose

Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.

Delivery

  • Amount 50 μg
  • Concentration 1 μg/μL
  • Pricing $495 USD
  • Storage 4 ℃ (short-term) or -20 ℃ (long-term)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry

Quality Control

Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.

Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.

Purpose

Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.

Delivery

  • Amount 100 μg
  • Concentration 1 μg/μL
  • Pricing $585 USD
  • Storage 4 ℃ (short-term) or -20 ℃ (long-term)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry

Quality Control

Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.

Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pKF-P14MMP2AG-T2APuroR-5h was a gift from Gabor Balazsi (Addgene plasmid # 128256 ; http://n2t.net/addgene:128256 ; RRID:Addgene_128256)
  • For your References section:

    Role of network-mediated stochasticity in mammalian drug resistance. Farquhar KS, Charlebois DA, Szenk M, Cohen J, Nevozhay D, Balazsi G. Nat Commun. 2019 Jun 24;10(1):2766. doi: 10.1038/s41467-019-10330-w. 10.1038/s41467-019-10330-w PubMed 31235692